Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
| Website: | www.alkermes.com |
| Email: | financial@alkermes.com |
| Main Phone: | +353 17728000 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House |
| City / Town: | Dublin |
| Country: | IE |
| Postal Code: | D04 C5Y6 |
| Exchange: | NGS |
| CEO: | Richard F. Pops |
| Employees: | 2235 |
| Issuer Type: | CS - Common Stock |
| Sector/Industry: | Healthcare |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Mapi Pharma Ltd. ($MAPI) is a development stage pharmaceutical company, engaged in the development of high-barrier to entry and high-added value generic drugs that include complex APIs,
The S&P Case/Shiller 20-City Home Price Index rose 0.3% month over month in September, the sixth consecutive monthly rise, and rose 3.0% year over year. The index is up 9.0% from its March
Advanced GDP for the third quarter came in a 2.0%. A month from now we get the preliminary report then a month later the final number. University of Michigan consumer sentiment came in at 82.6 in
Initial Jobless Claims came in at 370,000 still above the 350,000 recessionary threshold. The Philly Fed Index came in well below estimates at -5.8 in May when a +7.0 reading was expected. Leading
Debt can be a doubled-edged sword in business. No business can always expect to have the cash reserves ready to take advantage of opportunities that arise, and passing up certain chances for
New Home Sales fell 2.3% in August to an annual rate of just 295,000 units. The inventory of new homes fell to another new record low of 162,000 units. The price of a new home fell 7.7% year over
According to S&P Case Shiller home prices rose 3.6% in the second quarter, but were down 5.9% year over year. According to the Conference Board Consumer Confidence plunged to 44.5 in August
New Home Sales declined 0.7% in July to 298,000 units annualized. The inventory of new single family homes fell to a new record low at 165,000. The Richmond Fed Manufacturing Index fell to -10 in
Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
| Website: | www.alkermes.com |
| Email: | financial@alkermes.com |
| Main Phone: | +353 17728000 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House |
| City / Town: | Dublin |
| Country: | IE |
| Postal Code: | D04 C5Y6 |
| Exchange: | NGS |
| CEO: | Richard F. Pops |
| Employees: | 2235 |
| Issuer Type: | CS - Common Stock |
| Sector/Industry: | Healthcare |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Mapi Pharma Ltd. ($MAPI) is a development stage pharmaceutical company, engaged in the development of high-barrier to entry and high-added value generic drugs that include complex APIs,
The S&P Case/Shiller 20-City Home Price Index rose 0.3% month over month in September, the sixth consecutive monthly rise, and rose 3.0% year over year. The index is up 9.0% from its March
Advanced GDP for the third quarter came in a 2.0%. A month from now we get the preliminary report then a month later the final number. University of Michigan consumer sentiment came in at 82.6 in
Initial Jobless Claims came in at 370,000 still above the 350,000 recessionary threshold. The Philly Fed Index came in well below estimates at -5.8 in May when a +7.0 reading was expected. Leading
Debt can be a doubled-edged sword in business. No business can always expect to have the cash reserves ready to take advantage of opportunities that arise, and passing up certain chances for
New Home Sales fell 2.3% in August to an annual rate of just 295,000 units. The inventory of new homes fell to another new record low of 162,000 units. The price of a new home fell 7.7% year over
According to S&P Case Shiller home prices rose 3.6% in the second quarter, but were down 5.9% year over year. According to the Conference Board Consumer Confidence plunged to 44.5 in August
New Home Sales declined 0.7% in July to 298,000 units annualized. The inventory of new single family homes fell to a new record low at 165,000. The Richmond Fed Manufacturing Index fell to -10 in
| Last Price 18.03 | Change $ -0.42 | Change % -2.28 | Tick N/A |
| Bid 18.03 | Bid Size 100.00 | Ask 18.79 | Ask Size 400.00 |
| Open 18.72 | High 19.04 | Low 17.45 | Prev Close 18.45 |
| Last Trade | Volume 4.1 mi | 52 Wk Hi 21.88 | 52 Wk Low 11.98 |
| Market Cap 2.9 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 159,043,691.00 | EPS (TTM) -0.80 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 26 | 147 |
| Number of Buys | 11 | 73 |
| Number of Sells | 15 | 74 |
| Net Activity | -15686 | 139596 |
| Last 10 Buys | Shares |
|---|---|
| David W. Anstice | 1,000 |
| Wendy L. Dixon | 1,000 |
| Mark Stejbach | 1,000 |
| Floyd E Bloom | 1,000 |
| David W. Anstice | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| James M. Frates | 1,000 |
| Paul J. Mitchell | 1,000 |
| Michael J. Landine | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Michael J. Landine | 1,000 |
| Michael J. Landine | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Richard F. Pops | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 67 | 67 | 67 | 67 |
| Low Target Price Estimate | 46 | 46 | 46 | 46 |
| Mean Target Price Estimate | 56.13 | 55.57 | 55.57 | 56.13 |
| Standard Deviation | 7.32 | 7.72 | 7.72 | 7.32 |
| Date of Most Recent Estimate | 06/06/18 | 05/22/18 | 05/22/18 | 06/06/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| CT ORDER | 1 | 2018-05-30 | |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 4 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2 | 2.11 | 2.43 | 2.33 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait